Empatica Inc. has obtained Food and Drug Administration (FDA) approval for Embrace2, which employs AI (advanced machine learning) in a wristwatch. It uses Electrodermal Activity (EDA), a signal that stress researchers employ to measure physiological changes associated with sympathetic nervous system activity.
Magstim, Inc. developed ‘Horizon 3.0’, which has received clearance from the FDA (Food and Drug Administration) as a transcranial magnetic stimulation platform. It offers improved workflows with guided transcranial magnetic stimulation (TMS), and analytics for the therapeutic context.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?